ZEB1 and breast cancer: To explore its function in the M13HS tumor hybrids, which were derived from spontaneous fusion events between the human M13SV1-EGFP-Neo breast epithelial cells and the human HS578T-Hyg breast cancer cells [51], ZEB1 was knocked-out by CRISPR/Cas9.